Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

424 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Patient-reported burden of myasthenia gravis: baseline results of the international prospective, observational, longitudinal real-world digital study MyRealWorld-MG.
Dewilde S, Philips G, Paci S, Beauchamp J, Chiroli S, Quinn C, Day L, Larkin M, Palace J, Berrih-Aknin S, Claeys KG, Muppidi S, Mantegazza R, Saccà F, Meisel A, Bassez G, Murai H, Janssen MF. Dewilde S, et al. Among authors: palace j. BMJ Open. 2023 Jan 31;13(1):e066445. doi: 10.1136/bmjopen-2022-066445. BMJ Open. 2023. PMID: 36720569 Free PMC article.
Patient-reported impact of myasthenia gravis in the real world: findings from a digital observational survey-based study (MyRealWorld MG).
Berrih-Aknin S, Palace J, Meisel A, Claeys KG, Muppidi S, Saccà F, Amini F, Larkin M, Quinn C, Beauchamp J, Philips G, De Ruyck F, Ramirez J, Paci S. Berrih-Aknin S, et al. Among authors: palace j. BMJ Open. 2023 May 11;13(5):e068104. doi: 10.1136/bmjopen-2022-068104. BMJ Open. 2023. PMID: 37169499 Free PMC article.
A multicentre, prospective, double-blind study comparing the accuracy of autoantibody diagnostic assays in myasthenia gravis: the SCREAM study.
Li Z, Zhang C, Chang T, Zhang X, Yang H, Gao F, Feng J, Liu H, Chen S, Wang L, Yang C, Li H, Pan Y, Palace J, Shi FD; SCREAM Study Investigators. Li Z, et al. Among authors: palace j. Lancet Reg Health West Pac. 2023 Jul 19;38:100846. doi: 10.1016/j.lanwpc.2023.100846. eCollection 2023 Sep. Lancet Reg Health West Pac. 2023. PMID: 37554174 Free PMC article.
Brain reserve and physical disability in secondary progressive multiple sclerosis.
John N, Li Y, De Angelis F, Stutters J, Prados Carrasco F, Eshaghi A, Doshi A, Calvi A, Williams T, Plantone D, Phan T, Barkhof F, Chataway J; MS-SMART Investigators; Ourselin S, Braisher M, Beyene T, Bassan V, Zapata A, Chandran S, Connick P, Lyle D, Cameron J, Mollison D, Colville S, Dhillon B, Ross M, Cranswick G, Walker A, Smith L, Giovannoni G, Gnanapavan S, Nicholas R, Rashid W, Aram J, Ford H, Pavitt SH, Overell J, Young C, Arndt H, Duddy M, Guadagno J, Evangelou N, Craner M, Palace J, Hobart J, Sharrack B, Paling D, Hawkins C, Kalra S, McLean B, Stallard N, Bastow R. John N, et al. Among authors: palace j. BMJ Neurol Open. 2024 Sep 7;6(2):e000670. doi: 10.1136/bmjno-2024-000670. eCollection 2024. BMJ Neurol Open. 2024. PMID: 39262426 Free PMC article.
The influence of MOGAD on diagnosis of multiple sclerosis using MRI.
Geraldes R, Arrambide G, Banwell B, Rovira À, Cortese R, Lassmann H, Messina S, Rocca MA, Waters P, Chard D, Gasperini C, Hacohen Y, Mariano R, Paul F, DeLuca GC, Enzinger C, Kappos L, Leite MI, Sastre-Garriga J, Yousry T, Ciccarelli O, Filippi M, Barkhof F, Palace J; MAGNIMS Study Group. Geraldes R, et al. Among authors: palace j. Nat Rev Neurol. 2024 Sep 3. doi: 10.1038/s41582-024-01005-2. Online ahead of print. Nat Rev Neurol. 2024. PMID: 39227463 Review.
Study of seasonality of attacks in MOG antibody-associated disease.
Francis A, Santos M, Leal Rato M, Wintle YM, Brex P, Chen B, Cooper S, Dobson R, Geraldes R, Hemingway C, Huda S, Messina S, Ramdas S, Leite MI, Palace J. Francis A, et al. Among authors: palace j. Mult Scler Relat Disord. 2024 Oct;90:105814. doi: 10.1016/j.msard.2024.105814. Epub 2024 Aug 10. Mult Scler Relat Disord. 2024. PMID: 39151237
Protocol of a prospective multicenter study on comorbidity impact on multiple sclerosis and antibody-mediated diseases of the central nervous system (COMMIT).
Samadzadeh S, Adnan R, Berglova P, Barzegar M, Debrabant B, Roikjaer SG, Levy M, Petzold A, Palace J, Flanagan EP, Mariotto S, Skou ST, Froelich A, Lotan I, Messina S, Geraldes R, Asseyer S, Stiebel-Kalish H, Oertel FC, Shaygannejad V, Sahraian MA, Kim HJ, Bennett JL, Böttcher C, Zimmermann HG, Weinshenker BG, Paul F, Asgari N. Samadzadeh S, et al. Among authors: palace j. Front Immunol. 2024 Jul 2;15:1380025. doi: 10.3389/fimmu.2024.1380025. eCollection 2024. Front Immunol. 2024. PMID: 39021565 Free PMC article.
Sex ratio and age of onset in AQP4 antibody-associated NMOSD: a review and meta-analysis.
Arnett S, Chew SH, Leitner U, Hor JY, Paul F, Yeaman MR, Levy M, Weinshenker BG, Banwell BL, Fujihara K, Abboud H, Dujmovic Basuroski I, Arrambide G, Neubrand VE, Quan C, Melamed E, Palace J, Sun J, Asgari N, Broadley SA; Guthy Jackson International Clinical Consortium*. Arnett S, et al. Among authors: palace j. J Neurol. 2024 Aug;271(8):4794-4812. doi: 10.1007/s00415-024-12452-8. Epub 2024 Jul 3. J Neurol. 2024. PMID: 38958756 Free PMC article. Review.
Retinal Changes in Double-Antibody Seronegative Neuromyelitis Optica Spectrum Disorders.
Oertel FC, Zimmermann HG, Motamedi S, Bereuter C, Manthey LM, Ashtari F, Kafieh R, Dehghani A, Pourazizi M, Pandit L, D'Cunha A, Aktas O, Albrecht P, Ringelstein M, Martinez-Lapiscina EH, Sanchez Dalmau BF, Villoslada P, Asgari N, Marignier R, Cobo-Calvo A, Leocani L, Pisa M, Radaelli M, Palace J, Roca-Fernandez A, Leite MIS, Sharma S, De Seze J, Senger T, Yeaman MR, Smith TJ, Cook LJ, Brandt AU, Paul F; as the Guthy-Jackson Charitable Foundation. Oertel FC, et al. Among authors: palace j. Neurol Neuroimmunol Neuroinflamm. 2024 Sep;11(5):e200273. doi: 10.1212/NXI.0000000000200273. Epub 2024 Jun 28. Neurol Neuroimmunol Neuroinflamm. 2024. PMID: 38941573 Free PMC article.
424 results